University of Chicago-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Chicago - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013179
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Chicago (UOC) is an academic and research university that offers education and research in various disciplines. The university offers undergraduate, master’s and PhD programs in the areas of anthropology, art history, astronomy and astrophysics, biochemistry and molecular biology, biophysical sciences, business, cancer biology, chemistry, classics, comparative human development, statistics, religious studies, sociology, comparative literature, computational neuroscience and computer science, among others. It offers medical studies through Pritzker School of medicine. The university operates institutes and research centers in France, the US, China, India, Hong Kong and Bangladesh. UOC is headquartered in Chicago, Illinois, the US.

University of Chicago – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Chicago, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Chicago, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Chicago, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Chicago, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of Chicago, Medical Devices Deals, 2011 to YTD 2017 10
University of Chicago, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of Chicago, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
twoXAR Enters into Research Agreement with University of Chicago Department of Medicine 12
AbbVie Enters into Research Agreement with University of Chicago 13
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 14
Evelo Therapeutics Partners with University of Chicago 15
Celgene Partners with Recombinant Antibody Network 16
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 17
Merger 18
Advocate Health Care to Merge with NorthShore University Health System 18
Licensing Agreements 19
Evelo Biosciences Enters into Licensing Agreement with University of Chicago 19
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 20
University of Chicago – Key Competitors 21
University of Chicago – Key Employees 22
University of Chicago – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Strategy And Business Planning 25
Oct 27, 2016: Scientist Builds Drug Development Company Out of Research Lab 25
Government and Public Interest 27
Nov 17, 2017: Researchers receive $500,000 grant to study the microbiome of death 27
Nov 15, 2017: Wider sampling of tumor tissues may guide drug choice, improve outcomes 28
Nov 08, 2017: Novel approach could limit common complications of immunotherapy 30
Oct 19, 2017: Merck Foundation Launches Five-Year Initiative to Improve Diabetes Care for Vulnerable and Underserved U.S. Communities 31
Oct 18, 2017: Globus expands data services to accelerate secure cancer research 32
Sep 27, 2017: UChicago’s Ci3 receives NIH grant to increase access to HIV prevention medication in community pharmacies 33
Aug 24, 2017: Novel RNA Discoveries Could Improve Stem Cell Research 34
Oct 04, 2016: Revolutionary Clinical Trial Initiative Focuses on Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients 36
Sep 22, 2016: UChicago among Institutions Nationwide to Get $157 Million in NIH Awards 38
Jun 08, 2016: Antibodies triggered by avian influenza virus vaccine illuminate a new path toward a universal flu vaccine 40
Mar 21, 2016: Janssen Therapeutics Announces Funding for Organizations Focused on Improving Care and Treatment for Vulnerable Populations Living with HIV 41
Other Significant Developments 42
Jul 08, 2016: Rush Participating in NIH Precision Medicine Study of 1 Million 42
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
University of Chicago, Pharmaceuticals & Healthcare, Key Facts 2
University of Chicago, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Chicago, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Chicago, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Chicago, Deals By Therapy Area, 2011 to YTD 2017 9
University of Chicago, Medical Devices Deals, 2011 to YTD 2017 10
University of Chicago, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
twoXAR Enters into Research Agreement with University of Chicago Department of Medicine 12
AbbVie Enters into Research Agreement with University of Chicago 13
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 14
Evelo Therapeutics Partners with University of Chicago 15
Celgene Partners with Recombinant Antibody Network 16
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 17
Advocate Health Care to Merge with NorthShore University Health System 18
Evelo Biosciences Enters into Licensing Agreement with University of Chicago 19
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 20
University of Chicago, Key Competitors 21
University of Chicago, Key Employees 22
University of Chicago, Subsidiaries 23

★海外企業調査レポート[University of Chicago-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bonavista Energy Corp (BNP):企業の財務・戦略的SWOT分析
    Bonavista Energy Corp (BNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Fuji Seal International Inc.:戦略・SWOT・企業財務分析
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Beacon Roofing Supply Inc:企業のM&A・事業提携・投資動向
    Beacon Roofing Supply Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beacon Roofing Supply Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Tuesday Morning Corporation (TUES):企業の財務・戦略的SWOT分析
    Tuesday Morning Corporation (TUES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kangwon Land Inc.
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Polski Koncern Naftowy ORLEN SA:企業の戦略・SWOT・財務情報
    Polski Koncern Naftowy ORLEN SA - Strategy, SWOT and Corporate Finance Report Summary Polski Koncern Naftowy ORLEN SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Torc Oil and Gas Ltd (TOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Torc Oil and Gas Ltd (TORC) is an oil and gas company that offers oil and gas exploration and development services. The company’s services include acquisition, exploration, operations, management, production and development of crude oil and natural gas assets in Western Canadian Sedimentary …
  • Helix BioMedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Helix BioMedix Inc (Helix) is a dermatology and consumer skin care products company. It develops an extensive proprietary library of structurally diverse bioactive peptides for the applications in consumer skin care products and prescription products. Its peptides are used in cosmeceuticals, …
  • Suburban Propane Partners, L.P.:企業の戦略・SWOT・財務分析
    Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Almacenes Exito S.A.:企業の戦略・SWOT・財務情報
    Almacenes Exito S.A. - Strategy, SWOT and Corporate Finance Report Summary Almacenes Exito S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Conco, Inc.:企業の戦略・SWOT・財務情報
    Conco, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conco, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • BCD Travel Services B.V.:戦略・SWOT・企業財務分析
    BCD Travel Services B.V. - Strategy, SWOT and Corporate Finance Report Summary BCD Travel Services B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • QDVC Q.S.C:企業の戦略的SWOT分析
    QDVC Q.S.C - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • GridPoints Inc:企業の戦略的SWOT分析
    GridPoints Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Veikkaus Oy:企業の戦略的SWOT分析
    Veikkaus Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Samsung Engineering Co Ltd (028050):企業の財務・戦略的SWOT分析
    Samsung Engineering Co Ltd (028050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • MegaChips Corporation (6875):企業の財務・戦略的SWOT分析
    MegaChips Corporation (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • National Power Corporation:電力:M&Aディール及び事業提携情報
    Summary National Power Corporation (Napocor) is a government owned utility. It develops hydroelectric generation plants; produces power from nuclear, geothermal, and other sources; and transmits electricity across the country. The corporation preserves and protects the dams and watershed. Napocor’s …
  • Aegean Marine Petroleum Network Inc (ANWWQ):企業の戦略的SWOT分析
    Aegean Marine Petroleum Network Inc (ANWWQ) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆